A study from our laboratory established that the chemokine receptor CCR4 is a member of the molecular signature of melanoma brain metastasis and that its chemokine ligands CCL17 and CCL22 are expressed in microenvironmental brain cells.78 This evidence concerns the gene CCL17 and melanoma.